Thomas M Caparrotta

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Ankylosing Spondylitis

Coronavirus Disease

Glycemic Control

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Stuart J McGurnaghan, Paul M McKeigue, Luke A K Blackbourn, Joseph C Mellor, Thomas M Caparrotta, Naveed Sattar, Brian Kennon, David A McAllister, Sarah D Wild, Helen Martina Colhoun, null null
Impact of COVID-19 and Non-COVID-19 Hospitalized Pneumonia on Longer-Term Cardiovascular Mortality in People With Type 2 Diabetes: A Nationwide Prospective Cohort Study From Scotland. Diabetes care 47 (8) (2024)
Stuart J McGurnaghan, Paul M McKeigue, Luke A K Blackbourn, Joseph C Mellor, Thomas M Caparrotta, Naveed Sattar, Brian Kennon, David A McAllister, Sarah D Wild, Helen Martina Colhoun, null null
Impact of COVID-19 and Non-COVID-19 Hospitalized Pneumonia on Longer-Term Cardiovascular Mortality in People With Type 2 Diabetes: A Nationwide Prospective Cohort Study From Scotland. Diabetes care (2024)
Stuart J McGurnaghan, Paul M McKeigue, Luke A K Blackbourn, Joseph C Mellor, Thomas M Caparrotta, Naveed Sattar, Brian Kennon, David A McAllister, Sarah D Wild, Helen Martina Colhoun, null null
Impact of COVID-19 and Non-COVID-19 Hospitalized Pneumonia on Longer-Term Cardiovascular Mortality in People With Type 2 Diabetes: A Nationwide Prospective Cohort Study From Scotland. Diabetes care 47 (8) (2024)
Stuart J McGurnaghan, Paul M McKeigue, Luke A K Blackbourn, Joseph C Mellor, Thomas M Caparrotta, Naveed Sattar, Brian Kennon, David A McAllister, Sarah D Wild, Helen Martina Colhoun, null null
Impact of COVID-19 and Non-COVID-19 Hospitalized Pneumonia on Longer-Term Cardiovascular Mortality in People With Type 2 Diabetes: A Nationwide Prospective Cohort Study From Scotland. Diabetes care 47 (8) (2024)
Linsay McCallum, Stefanie Lip, Alexander McConnachie, Katriona Brooksbank, Iain M MacIntyre, Alexander S F Doney, Andrea Llano, Alisha Aman, Thomas M Caparrotta, Gareth Ingram, Isla S Mackenzie, Anna F Dominiczak, Thomas M MacDonald, David John Webb, Sandosh Padmanabhan
UMOD Genotype-Blinded Trial of Ambulatory Blood Pressure Response to Torasemide. Hypertension (Dallas, Tex. : 1979) (2024)
Stuart J McGurnaghan, Luke A K Blackbourn, Thomas M Caparrotta, Joseph C Mellor, Anna Barnett, Sandra MacRury, Naveed Sattar, John A McKnight, John R Petrie, Sam Philip, Robert S Lindsay, Katherine Hughes, David A McAllister, Graham P Leese, Ewan R Pearson, Sarah D Wild, Paul M McKeigue, Helen Martina Colhoun
Cohort profile: the Scottish Diabetes Research Network national diabetes cohort - a population-based cohort of people with diabetes in Scotland. BMJ open 12 (10) (2022)
Thomas M Caparrotta, Andrew M Greenhalgh, Karen Osinski, Robert M Gifford, Svenja Moser, Sarah H Wild, Rebecca M Reynolds, David J Webb, Helen M Colhoun
Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies. Diabetes therapy : research, treatment and education of diabetes and related disorders 12 (4) (2021)
Stuart J McGurnaghan, Paul M McKeigue, Stephanie H Read, Stefan Franzen, Ann-Marie Svensson, Marco Colombo, Shona Livingstone, Bassam Farran, Thomas M Caparrotta, Luke A K Blackbourn, Joseph C Mellor, Ioanna Thoma, Naveed Sattar, Sarah D Wild, Soffia Gudbjörnsdottir, Helen Martina Colhoun, null null
Development and validation of a cardiovascular risk prediction model in type 1 diabetes. Diabetologia 64 (9) (2021)
Andreas Hohn, Stuart McGurnaghan, Thomas M Caparrotta, Stuart J McGurnaghan, Joseph E O'Reilly, Luke A K Blackbourn, Rory J McCrimmon, Graham P Leese, John A McKnight, Brian Kennon, Robert S Lindsay, Naveed Sattar, Sarah D Wild, Paul M McKeigue, Helen Martina Colhoun, null null
The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes. Diabetologia 64 (6) (2021)
Stuart McGurnaghan, Fraser W Gibb, John A McKnight, Joseph E O'Reilly, Thomas M Caparrotta, Andreas Hohn, Stuart J McGurnaghan, Luke A K Blackbourn, Sara Hatam, Brian Kennon, Rory J McCrimmon, Graham P Leese, Sam Philip, Naveed Sattar, Paul M McKeigue, Helen Martina Colhoun, null null
Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study. Diabetologia 65 (1) (2021)
Thomas M Caparrotta, Jack B Templeton, Thomas A Clay, Sarah H Wild, Rebecca M Reynolds, David J Webb, Helen M Colhoun
Glucagon-Like Peptide 1 Receptor Agonist (GLP1RA) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies. Diabetes therapy : research, treatment and education of diabetes and related disorders 12 (4) (2021)
Paul M McKeigue, Amanda Weir, Jen Bishop, Stuart J McGurnaghan, Sharon Kennedy, David A McAllister, Chris Robertson, Rachael Wood, Nazir I Lone, Janet Murray, Thomas M Caparrotta, Alison Smith-Palmer, David Goldberg, Jim McMenamin, Colin Ramsay, Sharon Hutchinson, Helen Martina Colhoun, null null
Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study. PLoS medicine 17 (10) (2020)
Thomas M Caparrotta, James W Dear, Helen Martina Colhoun, David John Webb
Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision-making. British journal of clinical pharmacology 85 (9) (2019)